# Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT01069523** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 42 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Guanfacine Extended Release
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01069523
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01069523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01069523, "Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01069523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*